Company / EPS (Diluted)
Eton Pharmaceuticals, Inc. EPS (Diluted) History
FY2019-FY2021 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$1.03
FY2021
5-year range
-$1.03 / -$1.03
FY2019-FY2021
Trend
+82.2%
vs FY2020
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.50 to $-1.03 over the past 2 years.
Based on SEC 10-K filings.
-1.03 in FY2021.
Improved from $-2.50 to $-1.03 over the past 2 years.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2021, eps (diluted) increased 82.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | -$1.03 | +82.2% |
| FY2020 | -$5.80 | -132.0% |
| FY2019 | -$2.50 | - |
As of FY2021 · SEC 10-K · Updated Jun 24, 2026